JP2022515226A5 - - Google Patents

Info

Publication number
JP2022515226A5
JP2022515226A5 JP2021536271A JP2021536271A JP2022515226A5 JP 2022515226 A5 JP2022515226 A5 JP 2022515226A5 JP 2021536271 A JP2021536271 A JP 2021536271A JP 2021536271 A JP2021536271 A JP 2021536271A JP 2022515226 A5 JP2022515226 A5 JP 2022515226A5
Authority
JP
Japan
Application number
JP2021536271A
Other languages
Japanese (ja)
Other versions
JP7614647B2 (ja
JP2022515226A (ja
JPWO2020132456A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/067874 external-priority patent/WO2020132456A1/en
Publication of JP2022515226A publication Critical patent/JP2022515226A/ja
Publication of JPWO2020132456A5 publication Critical patent/JPWO2020132456A5/ja
Publication of JP2022515226A5 publication Critical patent/JP2022515226A5/ja
Application granted granted Critical
Publication of JP7614647B2 publication Critical patent/JP7614647B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021536271A 2018-12-20 2019-12-20 1型糖尿病、その他の自己免疫疾患の処置 Active JP7614647B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201862782646P 2018-12-20 2018-12-20
US201862782624P 2018-12-20 2018-12-20
US62/782,624 2018-12-20
US62/782,646 2018-12-20
US201962854289P 2019-05-29 2019-05-29
US201962854286P 2019-05-29 2019-05-29
US62/854,289 2019-05-29
US62/854,286 2019-05-29
PCT/US2019/067874 WO2020132456A1 (en) 2018-12-20 2019-12-20 Treating type 1 diabetes, other autoimmune diseases

Publications (4)

Publication Number Publication Date
JP2022515226A JP2022515226A (ja) 2022-02-17
JPWO2020132456A5 JPWO2020132456A5 (https=) 2023-01-11
JP2022515226A5 true JP2022515226A5 (https=) 2023-01-11
JP7614647B2 JP7614647B2 (ja) 2025-01-16

Family

ID=71101601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021536271A Active JP7614647B2 (ja) 2018-12-20 2019-12-20 1型糖尿病、その他の自己免疫疾患の処置

Country Status (4)

Country Link
US (1) US20220073963A1 (https=)
EP (1) EP3899039A4 (https=)
JP (1) JP7614647B2 (https=)
WO (1) WO2020132456A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060125916A (ko) 2004-03-01 2006-12-06 펩팀문, 인코포레이티드 자가면역 질병을 치료하기 위한 방법 및 조성물
US7960518B2 (en) * 2006-06-06 2011-06-14 Crucell Holland B.V. Human binding molecules having killing activity against enterococci and uses thereof
JP2010522537A (ja) * 2006-11-30 2010-07-08 ナビジェニクス インコーポレイティド 遺伝子分析系および方法
EP4219759A3 (en) 2010-05-06 2023-09-06 Adaptive Biotechnologies Corporation Monitoring health and disease status using clonotype profiles
EP3134132B1 (en) 2014-04-22 2019-07-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnostic of an autoimmune disease
WO2016100615A2 (en) 2014-12-18 2016-06-23 The University Of Chicago Methods and composition for neutralization of influenza

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021015080A2 (https=)
BR112021012348A2 (https=)
BR112021018250A2 (https=)